The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences’ drug for children with a rare genetic disorder that impairs copper…
Reuters Health Information
Source link : https://www.medscape.com/s/viewarticle/us-fda-approves-fortress-bio-and-zydus-treatment-rare-2026a100016v?src=rss
Author :
Publish date : 2026-01-13 12:56:00
Copyright for syndicated content belongs to the linked Source.
